Advertisement

Topics

Aerpio Pharmaceuticals Announces Appointment of Michael Rogers as Chief Financial Officer

08:00 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced today that Michael Rogers has been appointed Chief Financial Officer effective...

Other Sources for this Article

Investor & Media:
Aerpio Pharmaceuticals, Inc.
Dhaval Desai
Vice President of Medical Affairs
ddesai@aerpio.com
or
Burns McClellan, on behalf of Aerpio Pharmaceuticals, Inc.
Media:
Justin Jackson
jjackson@burnsmc.com
or
Investors:
Ami Bavishi
abavishi@burnsmc.com

NEXT ARTICLE

More From BioPortfolio on "Aerpio Pharmaceuticals Announces Appointment of Michael Rogers as Chief Financial Officer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...